Advertisement
Screener

BeyondSpring Inc. (BYSI) Cash and Restricted Cash

2.8 / 5 stars · 68/120 Roast Me

BeyondSpring Inc. Cash and Restricted Cash

BeyondSpring Inc. (BYSI) had Cash and Restricted Cash of $2.70 million as of 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Cash Flow › Cash

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14

  • 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.70M.
  • 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.04M.
  • 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7.79M.
  • 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $12.48M.
Period endCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
2026-06-30$2.70M
10-Q · filed 2026-08-14
2026-03-31$4.04M
10-Q · filed 2026-05-13
2025-12-31$7.79M
10-Q · filed 2026-08-14
2025-09-30$12.48M
10-Q · filed 2025-11-12
2025-06-30$9.54M
10-Q · filed 2026-08-14
2025-03-31$6.53M
10-Q · filed 2026-05-13
2024-12-31$2.92M
10-Q · filed 2026-08-14
2024-09-30$19.29M
10-Q · filed 2025-11-12
2024-06-30$4.62M
10-Q · filed 2025-08-13
2024-03-31$3.28M
10-Q · filed 2025-05-12
2023-12-31$15.34M
10-K · filed 2026-03-25
2022-12-31$27.52M
10-K · filed 2025-03-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
NANOVIRICIDES, INC. (NNVC)United States$0.031B
CHINA PHARMA HOLDINGS, INC. (CPHI)$0.032B
Propanc Biopharma, Inc. (PPCB)$0.032B-0.13
IGC Pharma, Inc. (IGC)United States$0.029B-5.98
Hepion Pharmaceuticals, Inc. (HEPA)United States$0.029B-0.62
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
KYNTRA BIO, INC. (KYNB)United States$0.028B0.17
Context Therapeutics Inc. (CNTX)United States$0.034B-1.10
ROCKWELL MEDICAL, INC. (RMTI)United States$0.035B
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30